These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 14968353)

  • 21. Thrombin-inducible platelet adhesion and regulation of the platelet seven-transmembrane thrombin receptor-1 (PAR-1): effects of unfractionated heparin and lepirudin.
    Reiter N; Eichelberger B; Kaider A; Panzer S
    Platelets; 2009 Dec; 20(8):582-7. PubMed ID: 19929245
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lepirudin: a bivalent direct thrombin inhibitor for anticoagulation therapy.
    Greinacher A
    Expert Rev Cardiovasc Ther; 2004 May; 2(3):339-57. PubMed ID: 15151481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alteration of pharmacokinetics of lepirudin caused by anti-lepirudin antibodies occurring after long-term subcutaneous treatment in a patient with recurrent VTE due to Behcets disease.
    Linnemann B; Greinacher A; Lindhoff-Last E
    Vasa; 2010 Feb; 39(1):103-7. PubMed ID: 20186683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sodium citrate 4% locking solution for central venous dialysis catheters--an effective, more cost-efficient alternative to heparin.
    Grudzinski L; Quinan P; Kwok S; Pierratos A
    Nephrol Dial Transplant; 2007 Feb; 22(2):471-6. PubMed ID: 17065193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant hirudin for cardiopulmonary bypass anticoagulation: a randomized, prospective, and heparin-controlled pilot study.
    Riess FC; Poetzsch B; Madlener K; Cramer E; Doll KN; Doll S; Lorke DE; Kormann J; Mueller-Berghaus G
    Thorac Cardiovasc Surg; 2007 Jun; 55(4):233-8. PubMed ID: 17546553
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of ecarin clotting time (ECT) with lepirudin therapy in heparin-induced thrombocytopenia and cardiopulmonary bypass.
    Fabrizio MC
    J Extra Corpor Technol; 2001 May; 33(2):117-25. PubMed ID: 11467439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anaphylactic and anaphylactoid reactions associated with lepirudin in patients with heparin-induced thrombocytopenia.
    Greinacher A; Lubenow N; Eichler P
    Circulation; 2003 Oct; 108(17):2062-5. PubMed ID: 14568897
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Keeping central venous lines open: a prospective comparison of heparin, vitamin C and sodium chloride sealing solutions in medical patients.
    Rabe C; Gramann T; Sons X; Berna M; González-Carmona MA; Klehr HU; Sauerbruch T; Caselmann WH
    Intensive Care Med; 2002 Aug; 28(8):1172-6. PubMed ID: 12185445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lepirudin in heparin-induced thrombocytopenia and extracorporeal membranous oxygenation.
    Dager WE; Gosselin RC; Yoshikawa R; Owings JT
    Ann Pharmacother; 2004 Apr; 38(4):598-601. PubMed ID: 14982973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lepirudin use in a neonate with heparin-induced thrombocytopenia.
    Nguyen TN; Gal P; Ransom JL; Carlos R
    Ann Pharmacother; 2003 Feb; 37(2):229-33. PubMed ID: 12549954
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experience with the double lumen Silastic catheter for hemoaccess.
    Bour ES; Weaver AS; Yang HC; Gifford RR
    Surg Gynecol Obstet; 1990 Jul; 171(1):33-9. PubMed ID: 2163116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lepirudin anticoagulation for heparin-induced thrombocytopenia.
    Deitcher SR; Topoulos AP; Bartholomew JR; Kichuk-Chrisant MR
    J Pediatr; 2002 Feb; 140(2):264-6. PubMed ID: 11865285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concentration of heparin-locking solution and risk of central venous hemodialysis catheter malfunction.
    Thomas CM; Zhang J; Lim TH; Scott-Douglas N; Hons RB; Hemmelgarn BR;
    ASAIO J; 2007; 53(4):485-8. PubMed ID: 17667236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lepirudin for heparin-induced thrombocytopenia.
    Med Lett Drugs Ther; 1998 Sep; 40(1036):94-5. PubMed ID: 9774965
    [No Abstract]   [Full Text] [Related]  

  • 35. [Deep venous thrombosis caused by central venous catheter].
    Lersch C; Paschalidis M; Theiss W
    Vasa; 1999 May; 28(2):71-8. PubMed ID: 10409916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fluid mechanics and clinical success of central venous catheters for dialysis--answers to simple but persisting problems.
    Ash SR
    Semin Dial; 2007; 20(3):237-56. PubMed ID: 17555490
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prospective randomized comparative evaluation of proximal valve polyurethane and distal valve silicone peripherally inserted central catheters.
    Ong CK; Venkatesh SK; Lau GB; Wang SC
    J Vasc Interv Radiol; 2010 Aug; 21(8):1191-6. PubMed ID: 20598573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of subcutaneous lepirudin in an obese surgical intensive care unit patient with heparin resistance.
    Inman KR; Gerlach AT
    Ann Pharmacother; 2009 Oct; 43(10):1714-8. PubMed ID: 19690218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of lepirudin during percutaneous vascular interventions in patients with heparin-induced thrombocytopenia.
    Cochran K; DeMartini TJ; Lewis BE; O Brien J; Steen LH; Grassman ED; Leya F
    J Invasive Cardiol; 2003 Nov; 15(11):617-21. PubMed ID: 14608129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of heparin-coated central venous lines to prevent catheter-related bloodstream infection.
    Abdelkefi A; Achour W; Ben Othman T; Ladeb S; Torjman L; Lakhal A; Ben Hassen A; Hsairi M; Ben Abdeladhim A
    J Support Oncol; 2007 Jun; 5(6):273-8. PubMed ID: 17624052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.